Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood

BackgroundGenomic profiling of peripheral blood reveals altered immunity in chronic fatigue syndrome (CFS) however interpretation remains challenging without immune demographic context. The object of this work is to identify modulation of specific immune functional components and restructuring of co-expression networks characteristic of CFS using the quantitative genomics of peripheral blood.MethodsGene sets were constructed a priori for CD4+ T cells, CD8+ T cells, CD19+ B cells, CD14+ monocytes and CD16+ neutrophils from published data. A group of 111 women were classified using empiric case definition (U.S. Centers for Disease Control and Prevention) and unsupervised latent cluster analysis (LCA). Microarray profiles of peripheral blood were analyzed for expression of leukocyte-specific gene sets and characteristic changes in co-expression identified from topological evaluation of linear correlation networks.ResultsMedian expression for a set of 6 genes preferentially up-regulated in CD19+ B cells was significantly lower in CFS (p = 0.01) due mainly to PTPRK and TSPAN3 expression. Although no other gene set was differentially expressed at p < 0.05, patterns of co-expression in each group differed markedly. Significant co-expression of CD14+ monocyte with CD16+ neutrophil (p = 0.01) and CD19+ B cell sets (p = 0.00) characterized CFS and fatigue phenotype groups. Also in CFS was a significant negative correlation between CD8+ and both CD19+ up-regulated (p = 0.02) and NK gene sets (p = 0.08). These patterns were absent in controls.ConclusionDissection of blood microarray profiles points to B cell dysfunction with coordinated immune activation supporting persistent inflammation and antibody-mediated NK cell modulation of T cell activity. This has clinical implications as the CD19+ genes identified could provide robust and biologically meaningful basis for the early detection and unambiguous phenotyping of CFS.

[1]  E. Hoffman,et al.  NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes. , 2005, Human immunology.

[2]  W. Strober,et al.  Lymphocyte phenotype and function in the chronic fatigue syndrome , 2004, Journal of Clinical Immunology.

[3]  P. Halloran,et al.  Early Loss of Renal Transcripts in Kidney Allografts: Relationship to the Development of Histologic Lesions and Alloimmune Effector Mechanisms , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  Suzanne D Vernon,et al.  The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome. , 2006, Pharmacogenomics.

[5]  L. Carmel,et al.  Gene expression profile of empirically delineated classes of unexplained chronic fatigue. , 2006, Pharmacogenomics.

[6]  Matej Oresic,et al.  Systematic construction of gene coexpression networks with applications to human T helper cell differentiation process , 2007, Bioinform..

[7]  Mark M. Gosink,et al.  Electronically subtracting expression patterns from a mixed cell population , 2007, Bioinform..

[8]  R. Moss,et al.  TNF-α and Chronic Fatigue Syndrome , 1999, Journal of Clinical Immunology.

[9]  M. Fletcher,et al.  Immunologic abnormalities in chronic fatigue syndrome , 1990, Journal of clinical microbiology.

[10]  N. Sasaki,et al.  A deletion mutation of the protein tyrosine phosphatase kappa (Ptprk) gene is responsible for T-helper immunodeficiency (thid) in the LEC rat , 2007, Mammalian Genome.

[11]  A. Komaroff,et al.  Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression , 2005, Clinical and experimental immunology.

[12]  M. Fletcher,et al.  Natural killer cell function in chronic fatigue syndrome , 2002 .

[13]  G. Reynolds,et al.  DOWNREGULATION OF THE TGF-BETA TARGET GENE , PTPRK , BY THE EPSTEIN-BARR VIRUS ENCODED EBNA 1 CONTRIBUTES TO THE GROWTH AND SURVIVAL OF HODGKIN ’ S LYMPHOMA CELLS , 2007 .

[14]  D. Marguet,et al.  Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen , 2003, European journal of immunology.

[15]  J. Vecchiet,et al.  Study of Immune Alterations in Patients with Chronic Fatigue Syndrome with Different Etiologies , 2004, International journal of immunopathology and pharmacology.

[16]  J. Fitzgerald,et al.  IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. , 2004, In vivo.

[17]  Anushya Muruganujan,et al.  PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification , 2003, Nucleic Acids Res..

[18]  R. Craddock,et al.  Identifying illness parameters in fatiguing syndromes using classical projection methods. , 2006, Pharmacogenomics.

[19]  U. Vollmer-Conna,et al.  An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. , 2006, Pharmacogenomics.

[20]  L. Hawkley,et al.  Social regulation of gene expression in human leukocytes , 2007, Genome Biology.

[21]  K. Famulski,et al.  Transcriptome Analysis Reveals Heterogeneity in the Injury Response of Kidney Transplants , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  G S Jhangri,et al.  Microarray Analysis of Rejection in Human Kidney Transplants Using Pathogenesis‐Based Transcript Sets , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  M. Fletcher,et al.  Chronic fatigue syndrome is associated with diminished intracellular perforin , 2005, Clinical and experimental immunology.

[24]  A. Tomoda,et al.  Cytokine production and modulation: Comparison of patients with chronic fatigue syndrome and normal controls , 2005, Psychiatry Research.

[25]  R. Tibshirani,et al.  On testing the significance of sets of genes , 2006, math/0610667.

[26]  C. V. van Noorden,et al.  The multifunctional or moonlighting protein CD26/DPPIV. , 2003, European journal of cell biology.

[27]  James F. Jones,et al.  Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study , 2005, BMC medicine.

[28]  J. Coligan,et al.  Role That Each NKG2A Immunoreceptor Tyrosine-Based Inhibitory Motif Plays in Mediating the Human CD94/NKG2A Inhibitory Signal , 2002, The Journal of Immunology.

[29]  D. Koller,et al.  A module map showing conditional activity of expression modules in cancer , 2004, Nature Genetics.

[30]  D. Lefkowitz,et al.  Macrophage–neutrophil interaction: A paradigm for chronic inflammation revisited , 2001, Immunology and cell biology.

[31]  W. Dippold,et al.  Inhibition of anti‐GD3‐ganglioside antibody‐induced proliferation of human CD8+ T cells by CD16+ natural killer cells , 1994, European journal of immunology.

[32]  M. Gladwin,et al.  Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. , 2004, Blood.

[33]  G. Reynolds,et al.  Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. , 2008, Blood.

[34]  I. Hickie,et al.  Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study , 2006, BMJ : British Medical Journal.

[35]  James F. Jones,et al.  Psychometric properties of the CDC Symptom Inventory for assessment of Chronic Fatigue Syndrome , 2005, Population health metrics.

[36]  R. Moss,et al.  TNF-alpha and chronic fatigue syndrome. , 1999, Journal of clinical immunology.

[37]  Suzanne D Vernon,et al.  Cost Effectiveness and Resource Allocation Open Access the Economic Impact of Chronic Fatigue Syndrome , 2022 .

[38]  Kenneth G. C. Smith,et al.  Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification , 2007, BMC Genomics.

[39]  S. Wessely,et al.  High levels of type 2 cytokine‐producing cells in chronic fatigue syndrome , 2004, Clinical and experimental immunology.

[40]  James F. Jones,et al.  Exercise responsive genes measured in peripheral blood of women with Chronic Fatigue Syndrome and matched control subjects , 2005, BMC Physiology.

[41]  F. Ferrari,et al.  Genomic expression during human myelopoiesis , 2007, BMC Genomics.

[42]  M. Antoni,et al.  Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: preliminary evidence for a subgroup? , 2006, Journal of psychosomatic research.

[43]  Qi Liu,et al.  Improving gene set analysis of microarray data by SAM-GS , 2007, BMC Bioinformatics.